Nyxoah SA EBITDA 2021-2023 | NYXH
Nyxoah SA Annual EBITDA (Millions of US $) |
|
---|---|
2023 | $-46 |
2022 | $-32 |
2021 | $-29 |
2020 | $-12 |
Nyxoah SA Quarterly EBITDA (Millions of US $) |
|
---|---|
2023-12-31 | $-11 |
2023-09-30 | $-11 |
2023-06-30 | $-12 |
2023-03-31 | $-12 |
2022-12-31 | $-9 |
2022-09-30 | $-8 |
2022-06-30 | $-7 |
2022-03-31 | $-8 |
2021-12-31 | |
2021-03-31 | $-6 |
2020-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.000B | $0.005B |
Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $37.024B | 20.33 |
Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
Axonics (AXNX) | United States | $3.435B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
10x Genomics (TXG) | United States | $3.022B | 0.00 |
Azenta (AZTA) | United States | $3.015B | 163.85 |
Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
Enovis (ENOV) | United States | $2.779B | 20.60 |
Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
Privia Health (PRVA) | United States | $2.238B | 99.26 |
Schrodinger (SDGR) | United States | $1.679B | 0.00 |
Omnicell (OMCL) | United States | $1.376B | 47.56 |
Phreesia (PHR) | United States | $1.237B | 0.00 |
Standard BioTools (LAB) | United States | $0.650B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
Talkspace (TALK) | United States | $0.451B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.431B | 0.00 |
Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
Pulmonx (LUNG) | United States | $0.342B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
Outset Medical (OM) | United States | $0.214B | 0.00 |
Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
American Well (AMWL) | United States | $0.150B | 0.00 |
Augmedix (AUGX) | United States | $0.128B | 0.00 |
TruBridge (TBRG) | United States | $0.121B | 5.17 |
MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
111 (YI) | China | $0.094B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
HeartBeam (BEAT) | United States | $0.055B | 0.00 |
Zepp Health (ZEPP) | China | $0.051B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
Movano (MOVE) | United States | $0.039B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
Cue Health (HLTH) | United States | $0.021B | 0.00 |
CareCloud (CCLD) | United States | $0.017B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Syra Health (SYRA) | United States | $0.012B | 0.00 |
Biotricity (BTCY) | United States | $0.011B | 0.00 |
ETAO (ETAO) | United States | $0.010B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |